Healing of old world cutaneous leishmaniasis in travelers treated with fluconazole: Drug effect or spontaneous evolution? - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles American Journal of Tropical Medicine and Hygiene Year : 2007

Healing of old world cutaneous leishmaniasis in travelers treated with fluconazole: Drug effect or spontaneous evolution?

Abstract

The efficacy of fluconazole was evaluated in 35 travelers with parasitologically proven imported Old World cutaneous leishmaniasis (CL). Leishmania major (mainly MON-25) was identified in 15 patients and strongly suspected given the transmission area in 12 of these patients. Daily oral fluconazole (200 mg/day for adults and 2.5 mg/kg/day for children) was prescribed for six weeks. Outcome definition was based on re-epithelialization rate at day 50. Of the 27 L. major-infected patients, 12 (44.4%) were cured. This cure rate is similar to the placebo cure rate from trials in L. major CL in which, as in the present report, the definition of outcome relied exclusively on re-epithelialization. These data question the assumption that oral fluconazole is consistently effective for treatment of CL caused by L. major.
Fichier principal
Vignette du fichier
tropmed_2007.pdf (365.71 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

pasteur-01375238 , version 1 (25-05-2021)

Licence

Copyright

Identifiers

Cite

Gloria Morizot, Pascal Delgiudice, Eric Caumes, Emmanuel Laffitte, Pierre Marty, et al.. Healing of old world cutaneous leishmaniasis in travelers treated with fluconazole: Drug effect or spontaneous evolution?. American Journal of Tropical Medicine and Hygiene, 2007, 76 (1), pp.48-52. ⟨10.4269/ajtmh.2007.76.48⟩. ⟨pasteur-01375238⟩
105 View
61 Download

Altmetric

Share

Gmail Facebook X LinkedIn More